Velosulin

RSS

insulin human (rDNA)

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Velosulin has been withdrawn at the request of the marketing authorisation holder.

This EPAR was last updated on 17/04/2009

Authorisation details

Product details
Name
Velosulin
Agency product number
EMEA/H/C/000423
Active substance
insulin human
International non-proprietary name (INN) or common name
insulin human (rDNA)
Therapeutic area (MeSH)
Diabetes Mellitus
Anatomical therapeutic chemical (ATC) code
A10AB01
Publication details
Marketing-authorisation holder
Novo Nordisk A/S
Revision
5
Date of issue of marketing authorisation valid throughout the European Union
07/10/2002
Contact address

Novo Allé
DK-2880 Bagsvaerd
Denmark

Product information

16/03/2008 Velosulin - EMEA/H/C/000423 - N/0007

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Drugs used in diabetes

Therapeutic indication

Treatment of diabetes mellitus.

Assessment history

How useful was this page?

Add your rating